Data / Form D filings / Vivorte Inc.
Vivorte Inc.: Form D filings
Vivorte Inc., a biotechnology company in Louisville, KY, filed 10 Form D notices with the SEC between 2011 and 2022. The latest, on July 21, 2022, reports $600,858 sold of a $2.5 million offering to 18 investors.
Find out what Vivorte Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1044 East Chestnut Street, Louisville, KY, 40204
- Phone
- (502) 714-7234
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1509210
The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2022 | New notice | $2,500,000 | $600,858 | $1,899,142 | 18 | Jul 7, 2022 | sec.gov |
| Mar 31, 2021 | New notice | $717,120 | $321,080 | $396,040 | 15 | Mar 26, 2021 | sec.gov |
| Sep 14, 2020 | New notice | $927,642 | $894,998 | $32,644 | 14 | Apr 15, 2020 | sec.gov |
| Sep 14, 2020 | Amendment | $1,730,000 | $835,001 | $894,999 | 22 | Feb 28, 2020 | sec.gov |
| Apr 28, 2020 | New notice | $1,730,000 | $991,745 | $738,255 | 20 | Feb 28, 2020 | sec.gov |
| Oct 3, 2019 | New notice | $350,000 | $350,000 | $0 | 5 | Jul 5, 2019 | sec.gov |
| Nov 29, 2018 | New notice | $1,500,000 | $410,000 | $1,090,000 | 8 | Sep 19, 2017 | sec.gov |
| Nov 29, 2018 | New notice | $1,500,000 | $902,224 | $597,776 | 30 | Nov 5, 2015 | sec.gov |
| Jul 25, 2013 | Amendment | $4,500,000 | $4,430,000 | $70,000 | 74 | Dec 30, 2010 | sec.gov |
| Jan 19, 2011 | New notice | $2,000,000 | $1,179,600 | $820,400 | 35 | Dec 30, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Wagner | Executive Officer | |
| Peter Weiss | Director | |
| Ruth Voor | Director | |
| Tyree Wilburn | Director | |
| Michael Voor | Director | |
| William Scheessele | Director | |
| Robert Saunders | Director |
Every Form D from the week of Jul 18, 2022 · All recent filings in Kentucky · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vivorte Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.